Skip to main content

Table 4 Symptoms reported at baseline: percentage of participants by self-reported MS type

From: Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

  All
(n = 967)
Benign
(n = 29)
Relapsing-remitting
(n = 347)
Primary progressive
(n = 202)
Secondary progressive
(n = 184)
Fatigue 80 38 80 83 83
Poor balance 75 35 64 90 89
Any pain, including visual pain 70 35 67 77 76
Any pain (not visual) 69 35 65 76 75
Muscle weakness 64 28 53 82 80
Problems with memory 57 35 58 57 59
Pins and needles/tingling 56 45 59 54 55
Decreased or worsening mobility 56 10 35 81 76
Muscle stiffness 54 21 48 64 67
Muscle spasms 53 17 44 66 67
Sensory loss/numbness 53 28 53 49 65
Loss of dexterity 52 21 41 65 70
Urinary urgency 49 38 44 49 57
Muscular pain 49 28 42 57 57
Problems with concentration 49 38 50 47 54
Urinary frequency 48 38 45 52 53
Constipation 44 28 40 48 52
Difficulties with co-ordination 43 14 33 56 56
Emotional lability 42 28 46 38 39
Joint pain 40 21 36 45 42
Feeling anxious 35 31 31 39 39
Urinary incontinence 30 24 19 39 41
Depression 30 21 28 31 30
Urinary hesitancy 29 14 24 31 39
Weight gain 28 10 23 33 32
Blurred vision 27 14 29 25 28
Sexual problems 27 14 23 29 36
Tremor 26 7 19 35 33
Burning pain 25 21 23 24 29
Shooting pain 23 10 21 23 26
Swallowing difficulties 21 7 13 27 28
Speech problems 21 7 16 26 25
Faecal incontinence 13 7 8 15 22
Other pain 13 10 12 13 14
Double vision 12 10 10 15 17
Weight loss 10 14 6 10 16
Diarrhoea 10 10 9 8 9
Painful vision 9 4 10 8 12
Colour desaturation 8 4 10 5 7
Pressure sores 4 0 2 8 6
  1. A total of 205 participants did not know their MS type, or did not report an MS type.